Clinical Trial Update: Pharmacokinetic Study to Compare the Blood Levels of Low vs High Metal Manufacture of Abatacept [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating abatacept blood levels with low versus high metal content has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 1 | Status: WITHDRAWN